Definium Therapeutics, Inc. (DFTX)

NASDAQ: DFTX · Real-Time Price · USD

42.32

+0.53 (1.27%)

At close: Aug 4, 2026, 4:00 PM EDT

41.55

-0.77 (-1.82%)

After-hours: Aug 4, 2026, 7:57 PM EDT

Definium Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	262.52	257.84	273.74	99.7	142.14	133.54
Short-Term Investments	110.9	153.76	-	-	-	-
Cash & Short-Term Investments	373.42	411.59	273.74	99.7	142.14	133.54
Cash Growth	75.78%	50.36%	174.55%	-29.86%	6.44%	66.73%
Other Current Assets	7.14	7.73	7.88	4.17	3.91	3.68
Total Current Assets	380.56	419.32	281.62	103.87	146.06	137.22
Other Intangible Assets	-	-	-	0.53	3.69	6.87
Goodwill	19.92	19.92	19.92	19.92	19.92	19.92
Other Long-Term Assets	0.81	0.86	0.61	0.22	0.33	-
Total Assets	401.29	440.1	302.15	124.54	169.99	164

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	7.13	5.35	2.01	4.14	2.11	4.18
Accrued Expenses	24.51	20.45	12.83	11.63	5.88	6.23
Other Current Liabilities	49.47	40.91	24.01	16.48	9.9	-
Total Current Liabilities	81.11	66.7	38.85	32.25	17.89	10.41
Long-Term Debt	40.77	40.58	21.85	14.13	-	-
Other Long-Term Liabilities	0.56	0.5	-	0.03	1.18	1.93
Total Long-Term Liabilities	41.33	41.08	21.85	14.16	1.18	1.93
Total Liabilities	122.44	107.77	60.7	46.41	19.08	12.34

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-in Capital	937.8	913.91	639.51	367.99	344.76	288.29
Accumulated Other Comprehensive Income	0.82	1.09	0.82	0.34	0.63	1.05
Retained Earnings	-659.77	-582.67	-398.88	-290.2	-194.47	-137.67
Shareholders' Equity	278.85	332.33	241.45	78.13	150.92	151.66
Total Liabilities & Equity	401.29	440.1	302.15	124.54	169.99	164

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	40.77	40.58	21.85	14.13	0	0
Net Cash (Debt)	332.65	371.01	251.89	85.58	142.14	133.54
Net Cash Growth	74.71%	47.29%	194.35%	-39.80%	6.44%	66.73%
Net Cash Per Share	3.49	4.15	3.58	2.19	4.61	4.88
Book Value	278.85	332.33	241.45	78.13	150.92	151.66
Book Value Per Share	2.93	3.72	3.43	2.00	4.89	5.54
Tangible Book Value	258.93	312.41	221.53	57.69	127.31	124.88
Tangible Book Value Per Share	2.72	3.50	3.14	1.47	4.13	4.56